Doug Kahn

Doug Kahn is the Executive Chairman of CytoTronics, a company focused on commercializing innovative drug discovery technologies from Harvard University, integrating wet chemistry, semiconductor technology, and AI. Prior to this role, Doug Kahn served as the Chairman and CEO of TetraGenetics Inc. for over a decade. Additional experience includes leadership positions at Thermo Fisher Scientific, Ahura Scientific Inc., PanAmSat, Advanced Visual Systems, Easel Corp, and McCormack & Dodge. Doug Kahn holds an MBA from Stanford University Graduate School of Business and a BS in Operations Research and Industrial Engineering from Cornell University.